Oregon State Pharmacy Association submits testimony to Oregon's PDAB

On May 6, the Oregon State Pharmacy Association (OSPA) submitted testimony for the Oregon Prescription Drug Affordability Board's May 2025 meeting, suggesting that the board eliminate PBM spread pricing to improve prescription drug affordability. Read it here.

Read the PDF.

Learn more about:

Upper payment limits

PBM reimbursement practices

Visit PSM's PDAB page to check the progress of affordability boards across the country.